Drug Shortage Report for XOLAIR
| Report ID | 224781 |
| Drug Identification Number | 02260565 |
| Brand name | XOLAIR |
| Common or Proper name | XOLAIR 150MG/5ML VIALS 1 X1 |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | OMALIZUMAB |
| Strength(s) | 150MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 1 X 5ML |
| ATC code | R03DX |
| ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2024-08-31 |
| Actual start date | |
| Estimated end date | 2024-09-30 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2024-04-10 |
| Company comments | Limited quantities available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-04-10 | French | Compare |
| v3 | 2024-04-10 | English | Compare |
| v2 | 2024-04-10 | French | Compare |
| v1 | 2024-04-10 | English | Compare |
Showing 1 to 4 of 4